2-(3-Bromo-4,5-dimethoxyphenyl)-5,6,7,8-tetrahydropyridylthieno[2,3-d]pyrimidin-4(3H)-one trifluoroacetic acid

ID: ALA4763475

PubChem CID: 162659164

Max Phase: Preclinical

Molecular Formula: C19H17BrF3N3O5S

Molecular Weight: 422.30

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCNC4)cc(Br)c1OC.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C17H16BrN3O3S.C2HF3O2/c1-23-11-6-8(5-10(18)14(11)24-2)15-20-16(22)13-9-3-4-19-7-12(9)25-17(13)21-15;3-2(4,5)1(6)7/h5-6,19H,3-4,7H2,1-2H3,(H,20,21,22);(H,6,7)

Standard InChI Key:  JARMNLONTWZJHI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   20.7193  -14.6492    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.1323  -15.3597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5410  -14.6467    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.4261  -15.7727    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.8426  -15.7727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5508  -15.3638    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8426  -16.5905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8636  -15.1925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8636  -16.0205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5788  -16.4326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5788  -14.7764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2940  -15.1925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2985  -16.0170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0843  -16.2704    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.0770  -14.9348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5580  -15.5985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3693  -15.5122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7059  -14.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2209  -14.0996    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4033  -14.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5271  -14.6782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0113  -15.3461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8341  -15.2602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1738  -14.5026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6804  -13.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8594  -13.9237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9169  -13.5156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9972  -14.4151    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4826  -15.0850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3172  -15.9275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9809  -16.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0113  -13.0798    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  1  0
  2  5  1  0
  5  6  1  0
  5  7  2  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 16  1  0
 15 12  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 20 27  2  0
 24 28  1  0
 28 29  1  0
 23 30  1  0
 30 31  1  0
 25 32  1  0
M  END

Associated Targets(Human)

KB-V1 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
518A2 (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.30Molecular Weight (Monoisotopic): 421.0096AlogP: 3.08#Rotatable Bonds: 3
Polar Surface Area: 76.24Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.83CX Basic pKa: 8.47CX LogP: 2.11CX LogD: 1.81
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.68Np Likeness Score: -1.01

References

1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R.  (2020)  Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones.,  189  [PMID:31958738] [10.1016/j.ejmech.2020.112060]

Source